Treatment of cutaneous T-cell lymphoma with oral alitretinoin.

about

Cutaneous T-Cell Lymphoma: A Review with a Focus on Targeted Agents.

P2860

Q34516083-31C17B23-59A3-4428-8A42-074E910E05D4

P2860

Treatment of cutaneous T-cell lymphoma with oral alitretinoin.

Item

http://www.wikidata.org/entity/Q51316502

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Treatment of cutaneous T-cell lymphoma with oral alitretinoin.

@en

Treatment of cutaneous T-cell lymphoma with oral alitretinoin.

@nl

type

Item

label

Treatment of cutaneous T-cell lymphoma with oral alitretinoin.

@en

Treatment of cutaneous T-cell lymphoma with oral alitretinoin.

@nl

prefLabel

Treatment of cutaneous T-cell lymphoma with oral alitretinoin.

@en

Treatment of cutaneous T-cell lymphoma with oral alitretinoin.

@nl

P1476

Treatment of cutaneous T-cell lymphoma with oral alitretinoin.

@en

P2093

C Kapser

http://www.w3.org/2001/XMLSchema#string

M Flaig

http://www.w3.org/2001/XMLSchema#string

S Molin

http://www.w3.org/2001/XMLSchema#string

T Herzinger

http://www.w3.org/2001/XMLSchema#string

T Ruzicka

http://www.w3.org/2001/XMLSchema#string

P2860

Oral alitretinoin (9-cis-retinoic acid) therapy for chronic hand dermatitis in patients refractory to standard therapy: results of a randomized, double-blind, placebo-controlled, multicenter trial

Alitretinoin.

Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial.

Mycosis fungoides and Sézary syndrome.

Treatment of cutaneous T-cell lymphoma with retinoids.

Modeling, synthesis and biological evaluation of potential retinoid X receptor (RXR) selective agonists: novel analogues of 4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic acid (bexarotene).

Acitretin for the treatment of cutaneous T-cell lymphoma.

Possible benefit of oral alitretinoin in T-lymphoproliferative diseases: a report of two patients with palmoplantar hyperkeratotic-rhagadiform skin changes and mycosis fungoides or Sézary syndrome.

P304

783-788

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JDV.12684

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-08-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25175592

http://www.w3.org/2001/XMLSchema#string

Treatment of cutaneous T-cell lymphoma with oral alitretinoin.

about

P2860

P2860

Treatment of cutaneous T-cell lymphoma with oral alitretinoin.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698